Wang et al. showed that high mRNA expression of MMP-19 and MMP-20 were independent predictors of poor outcome and resistance to several anti-cancer drugs in patients with ovarian serous carcinoma (Wang et al., 2019). The gene discussed is MMP20; the disease is cancer.